Bayamban, Eto H.
HRN: 22-57-27 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/07/2025
05/13/2025
IV
4.5g
Q8H
Complicated UTI (Yeast)
Waiting Final Action
Indication: Empirical De-escalation Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes